<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01369069</url>
  </required_header>
  <id_info>
    <org_study_id>15959</org_study_id>
    <secondary_id>U01NS069498</secondary_id>
    <nct_id>NCT01369069</nct_id>
  </id_info>
  <brief_title>Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial</brief_title>
  <acronym>SHINE</acronym>
  <official_title>Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Neurological Emergencies Treatment Trials Network (NETT)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial is a multicenter, randomized,
      controlled clinical trial of 1400 patients that will include approximately 60 enrolling
      sites. The study hypotheses are that treatment of hyperglycemic acute ischemic stroke
      patients with targeted glucose concentration (80mg/dL - 130 mg/dL) will be safe and result in
      improved 3 month outcome after stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible subjects must be randomized within 12 hours of stroke symptom onset and either have
      type 2 diabetes and glucose concentrations of over 110 mg/dL or no history of diabetes and
      glucose concentrations of 150 mg/dL or higher on initial evaluation. The enrolling sites
      include the Neurological Emergencies Treatment Trials (NETT) sites as well as non NETT sites
      from all over the United States. The study evaluates the safety and efficacy of targeted
      glucose control (treatment group - IV insulin with target 80-130 mg/dl) verses control
      therapy of sub q insulin plus basal insulin with target glucose less than 180 mg/ dL.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2012</start_date>
  <completion_date type="Actual">November 19, 2018</completion_date>
  <primary_completion_date type="Actual">November 19, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With a Favorable Modified Rankin Scale (Yes/No)</measure>
    <time_frame>90 days (-14/+30 days)</time_frame>
    <description>Favorable for the primary efficacy outcome is defined as modified Rankin Scale (mRS) score of 0 in patients with mild stroke (baseline NIHSS 3-7), mRS 0 or 1 in patients with moderate stroke (baseline NIHSS 8-14), and mRS 0, 1 or 2 in patients with severe stroke (baseline NIHSS 15-22) at 90 days with a pre-specified range of acceptable days of 76 -120 days. The mRS is a stroke outcome scale used to assess functional status after stroke. It consists of seven levels (0-6) where 0 indicates no residual symptoms at all, 5 indicates severe disability and 6 indicates death. The person collecting the mRS score was to be blinded to the participant's treatment group assignment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Severe Hypoglycemia (Blood Glucose &lt; 40mg/dL)</measure>
    <time_frame>72 hours</time_frame>
    <description>Severe hypoglycemia (blood glucose &lt; 40mg/dL) is the primary safety outcome and will be measured during the 72 hour treatment period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a Favorable NIHSS</measure>
    <time_frame>Follow up (Max 164 days)</time_frame>
    <description>The NIHSS (National Institutes of Health Stroke Scale) score ranges from 0 to 42, with higher scores indicating greater neurological deficits. A favorable NIHSS was defined as a score of 0 or 1 on the NIHSS at 90 days post randomization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a Favorable Barthel Index</measure>
    <time_frame>Follow up (Max 164 days)</time_frame>
    <description>Favorable outcomes for the Barthel Index was defined as a score of 95-100 on the BI at 90 days post randomization. Barthel - Barthel Index for Activities of Daily Living (ADL) assesses functional independence, generally in stroke patients. Scores range from 0-100 with higher scores indicating greater ability to perform activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Specific Quality of Life (SSQOL)</measure>
    <time_frame>Follow up (Max 164 days)</time_frame>
    <description>Stroke Specific Quality of Life. Scores range from 1-5 with higher scores indicating better quality of life</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Death</measure>
    <time_frame>90 days (+30 days)</time_frame>
    <description>Death from any cause</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1151</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <condition>Diabetes</condition>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>IV insulin drip with target glucose 80 mg/dL - 130 mg/dL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sub Q insulin to keep glucose less than 180 mg/dL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV insulin to maintain target glucose concentration of 80-130 mg/dL</intervention_name>
    <description>Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
    <arm_group_label>IV insulin drip with target glucose 80 mg/dL - 130 mg/dL</arm_group_label>
    <other_name>Continuous intravenous insulin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL</intervention_name>
    <description>Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
    <arm_group_label>Sub Q insulin to keep glucose less than 180 mg/dL</arm_group_label>
    <other_name>Sliding scale insulin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years or older

          2. Clinical diagnosis of ischemic stroke defined as acute neurological deficit occurring
             in one or more cerebral vascular territories. Neuroimaging must be done to exclude
             intracranial hemorrhage (ICH).

          3. Randomization must be within 12 hours after stroke symptom onset and treatment is
             recommended, but not required, to begin within 3 hours after hospital arrival. If time
             of symptom onset is unclear or patient is awakening with stroke symptoms, the time of
             onset will be the time the patient was last known to be normal.

          4. Known history of type 2 diabetes mellitus and glucose &gt;110 mg/dL OR admission blood
             glucose â‰¥150 mg/dL in those w/o known diabetes mellitus

          5. Baseline NIHSS score of 3-22

          6. Pre-stroke modified Rankin Scale score = 0 for patients with an NIHSS score of 3-7.
             Pre-stroke modified Rankin Scale score = 0 or 1 for patients with an NIHSS score of
             8-22.

          7. Able to provide a valid informed consent to be in the study (self or their authorized
             legally accepted representative). The approved consent form must be signed and dated
             in accordance with federal and institutional guidelines.

        Exclusion Criteria:

          1. Known history of type 1 diabetes mellitus

          2. Substantial pre-existing neurological or psychiatric illness that would confound the
             neurological assessment or other outcome assessment

          3. Having received experimental therapy for the enrollment stroke. IV tPA (up to 4.5 hrs)
             or IA tPA are allowed as are IA therapies including use of FDA cleared devices. Non
             FDA cleared devices are considered experimental and are excluded.

          4. Pregnant or breast-feeding at the time of study entry

          5. Other serious conditions that make the patient unlikely to survive 90 days

          6. Inability to follow the protocol or return for the 90 day follow up

          7. Renal dialysis (including hemo or peritoneal dialysis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen C Johnston, MD, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christiana Hall, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Askiel Bruno, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augusta University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valerie Durkalski, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Barsan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kevin Barrett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arizona Medical Center - South Campus</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ronald Regan Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center - Davies Campus</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center-Pacific Campus</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital - Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University Medical Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSF Saint Francis Medical Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Detroit Receiving Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai-Grace Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center, Fairview</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>08818</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lincoln Medical and Mental Health Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10451</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings County Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Downstate University Hospital of Brooklyn</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buffalo General Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Akron City Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC - Mercy</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WellSpan York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Thomas Neuroscience Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dell Seton Medical Center at UT</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seton Medical Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern-Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern-Zale Lipshy University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Baptist Medical Center</name>
      <address>
        <city>Harlingen</city>
        <state>Texas</state>
        <zip>78552</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Herman Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Froedtert Memorial Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://nett.umich.edu/clinical-trials/shine</url>
    <description>General information of trial</description>
  </link>
  <results_reference>
    <citation>Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 Jul 23;322(4):326-335. doi: 10.1001/jama.2019.9346. Erratum in: JAMA. 2019 Nov 5;322(17):1718.</citation>
    <PMID>31334795</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 6, 2011</study_first_submitted>
  <study_first_submitted_qc>June 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2011</study_first_posted>
  <results_first_submitted>November 6, 2019</results_first_submitted>
  <results_first_submitted_qc>November 26, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 16, 2019</results_first_posted>
  <last_update_submitted>December 13, 2019</last_update_submitted>
  <last_update_submitted_qc>December 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Karen C. Johnston</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>diabetes</keyword>
  <keyword>hyperglycemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 23, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT01369069/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 8, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT01369069/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between April 2012 and August 2018, a total of 70 United States sites were included in the trial, and 63 sites enrolled at least one patient.</recruitment_details>
      <pre_assignment_details>28977 patients were excluded after screening. Of those, 27344 did not meet eligibility criteria; 1156 were unable to provide informed consent or refused participation; 342 had other reasons and 135 did not specify a reason.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
          <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
        </group>
        <group group_id="P2">
          <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
          <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="581"/>
                <participants group_id="P2" count="570"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="564"/>
                <participants group_id="P2" count="554"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
          <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
        </group>
        <group group_id="B2">
          <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
          <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="581"/>
            <count group_id="B2" value="570"/>
            <count group_id="B3" value="1151"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" lower_limit="57" upper_limit="75"/>
                    <measurement group_id="B2" value="66" lower_limit="57" upper_limit="76"/>
                    <measurement group_id="B3" value="66" lower_limit="57" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="260"/>
                    <measurement group_id="B2" value="264"/>
                    <measurement group_id="B3" value="524"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="321"/>
                    <measurement group_id="B2" value="306"/>
                    <measurement group_id="B3" value="627"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="178"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="460"/>
                    <measurement group_id="B2" value="449"/>
                    <measurement group_id="B3" value="909"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="180"/>
                    <measurement group_id="B2" value="154"/>
                    <measurement group_id="B3" value="334"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="366"/>
                    <measurement group_id="B2" value="368"/>
                    <measurement group_id="B3" value="734"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Final diagnosis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Ischemic stroke</title>
                  <measurement_list>
                    <measurement group_id="B1" value="542"/>
                    <measurement group_id="B2" value="524"/>
                    <measurement group_id="B3" value="1066"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Transient ischemic attack</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Thrombolysis or Thrombectomy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Intravenous tPA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="372"/>
                    <measurement group_id="B2" value="353"/>
                    <measurement group_id="B3" value="725"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mechanical treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intraarterial drug therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medical History</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="513"/>
                    <measurement group_id="B2" value="502"/>
                    <measurement group_id="B3" value="1015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes mellitus (Type 2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="468"/>
                    <measurement group_id="B2" value="455"/>
                    <measurement group_id="B3" value="923"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperlipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="350"/>
                    <measurement group_id="B2" value="327"/>
                    <measurement group_id="B3" value="677"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coronary artery disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="167"/>
                    <measurement group_id="B3" value="326"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Atrial fibrillation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous Ischemic stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous large vessel atherosclerosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Eligibility POC blood glucose (mg/dL)</title>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="188" lower_limit="153" upper_limit="250"/>
                    <measurement group_id="B2" value="187" lower_limit="155" upper_limit="248"/>
                    <measurement group_id="B3" value="187.5" lower_limit="154" upper_limit="250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline NIHSS at randomization</title>
          <units>NIHSS score range: 0 to 42</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7" lower_limit="5" upper_limit="12"/>
                    <measurement group_id="B2" value="7" lower_limit="5" upper_limit="13"/>
                    <measurement group_id="B3" value="7" lower_limit="5" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline NIHSS category at randomization</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Mild (NIHSS 3-7)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="291"/>
                    <measurement group_id="B2" value="291"/>
                    <measurement group_id="B3" value="582"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate (NIHSS 8-14)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="177"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="335"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe (NIHSS 15-22)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                    <measurement group_id="B2" value="121"/>
                    <measurement group_id="B3" value="234"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With a Favorable Modified Rankin Scale (Yes/No)</title>
        <description>Favorable for the primary efficacy outcome is defined as modified Rankin Scale (mRS) score of 0 in patients with mild stroke (baseline NIHSS 3-7), mRS 0 or 1 in patients with moderate stroke (baseline NIHSS 8-14), and mRS 0, 1 or 2 in patients with severe stroke (baseline NIHSS 15-22) at 90 days with a pre-specified range of acceptable days of 76 -120 days. The mRS is a stroke outcome scale used to assess functional status after stroke. It consists of seven levels (0-6) where 0 indicates no residual symptoms at all, 5 indicates severe disability and 6 indicates death. The person collecting the mRS score was to be blinded to the participant's treatment group assignment.</description>
        <time_frame>90 days (-14/+30 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
            <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
          </group>
          <group group_id="O2">
            <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
            <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Favorable Modified Rankin Scale (Yes/No)</title>
          <description>Favorable for the primary efficacy outcome is defined as modified Rankin Scale (mRS) score of 0 in patients with mild stroke (baseline NIHSS 3-7), mRS 0 or 1 in patients with moderate stroke (baseline NIHSS 8-14), and mRS 0, 1 or 2 in patients with severe stroke (baseline NIHSS 15-22) at 90 days with a pre-specified range of acceptable days of 76 -120 days. The mRS is a stroke outcome scale used to assess functional status after stroke. It consists of seven levels (0-6) where 0 indicates no residual symptoms at all, 5 indicates severe disability and 6 indicates death. The person collecting the mRS score was to be blinded to the participant's treatment group assignment.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="581"/>
                <count group_id="O2" value="570"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                    <measurement group_id="O2" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>It was hypothesized that intensive blood glucose control would be efficacious and safe in acute ischemic stroke patients compared to standard glucose control.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.55</p_value>
            <p_value_desc>The a priori threshold for statistical significance was 0.05.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.97</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.08</ci_upper_limit>
            <estimate_desc>Adjusted for baseline NIHSS strata (3-7, 8-14, 15-22) and thrombolysis use (Yes/No; includes both IV and IA therapies). Multiple imputation was used for missing data.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Severe Hypoglycemia (Blood Glucose &lt; 40mg/dL)</title>
        <description>Severe hypoglycemia (blood glucose &lt; 40mg/dL) is the primary safety outcome and will be measured during the 72 hour treatment period.</description>
        <time_frame>72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
            <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
          </group>
          <group group_id="O2">
            <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
            <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Severe Hypoglycemia (Blood Glucose &lt; 40mg/dL)</title>
          <description>Severe hypoglycemia (blood glucose &lt; 40mg/dL) is the primary safety outcome and will be measured during the 72 hour treatment period.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="581"/>
                <count group_id="O2" value="570"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>2.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.29</ci_lower_limit>
            <ci_upper_limit>3.87</ci_upper_limit>
            <estimate_desc>The data of the estimation parameter and the confidence intervals were presented as percentages.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a Favorable NIHSS</title>
        <description>The NIHSS (National Institutes of Health Stroke Scale) score ranges from 0 to 42, with higher scores indicating greater neurological deficits. A favorable NIHSS was defined as a score of 0 or 1 on the NIHSS at 90 days post randomization.</description>
        <time_frame>Follow up (Max 164 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
            <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
          </group>
          <group group_id="O2">
            <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
            <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Favorable NIHSS</title>
          <description>The NIHSS (National Institutes of Health Stroke Scale) score ranges from 0 to 42, with higher scores indicating greater neurological deficits. A favorable NIHSS was defined as a score of 0 or 1 on the NIHSS at 90 days post randomization.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="348"/>
                <count group_id="O2" value="371"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152"/>
                    <measurement group_id="O2" value="166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.77</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-1.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.33</ci_lower_limit>
            <ci_upper_limit>6.20</ci_upper_limit>
            <estimate_desc>The data of the estimation parameter and the confidence intervals were presented as percentages.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a Favorable Barthel Index</title>
        <description>Favorable outcomes for the Barthel Index was defined as a score of 95-100 on the BI at 90 days post randomization. Barthel - Barthel Index for Activities of Daily Living (ADL) assesses functional independence, generally in stroke patients. Scores range from 0-100 with higher scores indicating greater ability to perform activities of daily living.</description>
        <time_frame>Follow up (Max 164 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
            <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
          </group>
          <group group_id="O2">
            <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
            <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Favorable Barthel Index</title>
          <description>Favorable outcomes for the Barthel Index was defined as a score of 95-100 on the BI at 90 days post randomization. Barthel - Barthel Index for Activities of Daily Living (ADL) assesses functional independence, generally in stroke patients. Scores range from 0-100 with higher scores indicating greater ability to perform activities of daily living.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="491"/>
                <count group_id="O2" value="477"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="271"/>
                    <measurement group_id="O2" value="261"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.88</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.48</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.79</ci_lower_limit>
            <ci_upper_limit>6.75</ci_upper_limit>
            <estimate_desc>The data of the estimation parameter and the confidence intervals were presented as percentages.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke Specific Quality of Life (SSQOL)</title>
        <description>Stroke Specific Quality of Life. Scores range from 1-5 with higher scores indicating better quality of life</description>
        <time_frame>Follow up (Max 164 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
            <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
          </group>
          <group group_id="O2">
            <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
            <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke Specific Quality of Life (SSQOL)</title>
          <description>Stroke Specific Quality of Life. Scores range from 1-5 with higher scores indicating better quality of life</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="432"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.75" lower_limit="2.98" upper_limit="4.40"/>
                    <measurement group_id="O2" value="3.69" lower_limit="3.02" upper_limit="4.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.74</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.13</ci_lower_limit>
            <ci_upper_limit>0.25</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Death</title>
        <description>Death from any cause</description>
        <time_frame>90 days (+30 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
            <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
          </group>
          <group group_id="O2">
            <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
            <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
          </group>
        </group_list>
        <measure>
          <title>Death</title>
          <description>Death from any cause</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="581"/>
                <count group_id="O2" value="570"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.24</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>1.15</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Non-serious adverse events were assessed and reported through the treatment period (up to 72 hours). Serious adverse events were reported throughout the study period (randomization through end of study; end of study was 90 days post randomization or earlier if a participant died or withdrew consent).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>IV Insulin Drip With Target Glucose 80 mg/dL - 130 mg/dL</title>
          <description>The intervention arm will have a targeted glucose concentration of 80-130 mg/dL. IV insulin drip will be titrated to keep glucose concentration in this range.
IV insulin to maintain target glucose concentration of 80-130 mg/dL: Intervention is to keep glucose concentration 80-130 mg/dL for up to 72 hours after randomization. IV insulin drip will be used to maintain glucose target.</description>
        </group>
        <group group_id="E2">
          <title>Sub Q Insulin to Keep Glucose Less Than 180 mg/dL</title>
          <description>This standard care arm will get sub q insulin sliding scale to keep glucose concentration less than 180 mg/dL
Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL: Sliding scale sub q insulin given will be given up to 4 times per day based on glucose concentration. It will be given only if glucose concentration greater than or equal to 180 mg/dL.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="581"/>
                <counts group_id="E2" subjects_affected="65" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="209" subjects_at_risk="581"/>
                <counts group_id="E2" subjects_affected="198" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="10" subjects_affected="7" subjects_at_risk="581"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="581"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="581"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="21" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Vitamin B12 deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="581"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="581"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="581"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="581"/>
                <counts group_id="E2" events="28" subjects_affected="27" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="581"/>
                <counts group_id="E2" events="21" subjects_affected="16" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="581"/>
                <counts group_id="E2" events="18" subjects_affected="17" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Stroke in evolution</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="581"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="581"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="581"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="581"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="384" subjects_at_risk="581"/>
                <counts group_id="E2" subjects_affected="134" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="581"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="581"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter site haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated partial thromboplastin time prolonged</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Blood chloride increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Blood cholesterol increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Blood creatinine decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Blood sodium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Carbon dioxide decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>High density lipoprotein decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="12" subjects_affected="8" subjects_at_risk="581"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Red cell distribution width increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyperchloraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="574" subjects_affected="311" subjects_at_risk="581"/>
                <counts group_id="E2" events="26" subjects_affected="16" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Vitamin B12 deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="581"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="581"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="581"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Stroke in evolution</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="581"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="581"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="581"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Malignant hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Other (combined AEs happened only once)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="581"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="570"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Karen C. Johnston, MD</name_or_title>
      <organization>University of Virginia</organization>
      <phone>434 924-5323</phone>
      <email>kj4v@virginia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

